-+ 0.00%
-+ 0.00%
-+ 0.00%

CITY THERAPEUTICS ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 CLINICAL TRIAL OF CITY-RBP4 FOR THE TREATMENT OF STARGARDT DISEASE

Reuters·11/10/2026 12:00:00

Please log in to view news